Back

HDL structural and compositional alterations in type 2 diabetes mellitus patients: identifying potential biomarkers for subclinical atherosclerosis detection and disease progression

18 April 2026 (08:30 - 18:00)
Organised by: Logo
Congress Presentation Part of: Poster session (2) Biomarkers Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

About the speaker

Photo
Ms Gabriela Obdulia Giron Martinez

Research Institute - Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)

37 More presentations in this session

Presentation thumbnail
Conditions mimicking obesity result in mitochondrial dysfunction in three-dimensional in vitro cardiovascular spheroid models
Doctor M. Blignaut (Cape Town, ZA)
Abstract
Presentation thumbnail
Evaluation of bile-scid profiles and functional capacity before and after bariatric surgery
Doctor S. Wolf (Graz, AT)
Abstract
Presentation thumbnail
Multiomics of maladaptive cardiac energy metabolism in the progression of multimorbid cardiovascular disease
Doctor D. Bernieh (Leicester, GB)
Abstract
Presentation thumbnail
Unraveling the role of iron in the heart using 3D engineered heart tissue
Mr S. Majoor (Groningen, NL)
Abstract
Presentation thumbnail
Designing and development of a novel efflux assay based on liposome and macrophage to evaluate hdl's reverse cholesterol transport capacity
Miss S. Varshney (New Delhi, IN)
Abstract

Access the full session

Session thumbnail
Poster session (2)

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

18 April 2026 08:30 CET
You may be interested in
thumbnail
Congress Presentation
High levels of small dense LDL cholesterol potentiate the risk of poor glycemic management for long-term prognosis in patients with stable coronary artery disease
1 September 2025
thumbnail
Congress Presentation
A proteomic atlas of atherosclerosis: regional proteomic signatures for plaque inflammation and calcification
30 April 2022
thumbnail
Congress Presentation
Association of HDL composition and functionality with markers of subclinical vascular disease in individuals with extremely high HDL
30 August 2025
thumbnail
Congress Presentation
Apolipoprotein B and cardiovascular risk in asymptomatic patients: need for systematic evaluation?
14 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources